Publication | Open Access

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age

Phosphohistone H3 ExpressionBreast OncologyMedicinePathologyStronger Prognostic ValueBreast CancerCancer TreatmentOncologyCell BiologyTumor MicroenvironmentCancer ResearchClassical Prognosticators